Human Albumin 20% Biotest Low Salt Content Malta - engelsk - Medicines Authority

human albumin 20% biotest low salt content

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human plasma, protein - solution for infusion - human plasma protein 200 g/l - blood substitutes and perfusion solutions

HUMAN ALBUMIN GRIFOLS (albumin- human solution USA - engelsk - NLM (National Library of Medicine)

human albumin grifols (albumin- human solution

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used.1,2,3 acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. human albumin grifols® 25% can be used in such cases.1 human albumin grifols 25% may be of value in the treatment of shock or hypotension in renal dialysis patients.1 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid.4,5,6 human albumin grifols 25% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics.1,2,7 human albumin grifols 25% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when

Cinryze Den europeiske union - latvisk - EMA (European Medicines Agency)

cinryze

takeda manufacturing austria ag - c1 inhibitors (human) - angioedēma, iedzimta - c1-inhibitors, asins plazmas, narkotikas lieto iedzimta angioedēma - angioneirotiskā tūskas uzbrukumu ārstēšana un pirmsprocedūras profilakse pieaugušajiem, pusaudžiem un bērniem (no 2 gadu vecuma un vecākiem) ar iedzimtu angioneirotisko tūsku (hae). ikdienas profilakses angioedēma uzbrukumiem pieaugušajiem, pusaudžiem un bērniem (6 gadi un vairāk) ar smagu un atkārtotas lēkmes iedzimta angioedēma (hae), kas nepanes vai nepietiekami aizsargā mutes profilakses ārstēšanu, vai pacientiem, kuriem ir nepietiekami pārvalda ar atkārtotu akūta ārstēšana.

Berinert 2000 IE pulver og solvens til injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

berinert 2000 ie pulver og solvens til injektionsvæske, opløsning

csl behring gmbh - c1-esterase inhibitor, human - pulver og solvens til injektionsvæske, opløsning - 2000 ie

Berinert 500 IE pulver og solvens til injektions- /infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

berinert 500 ie pulver og solvens til injektions- /infusionsvæske, opløsning

paranova danmark a/s - c1-esterase inhibitor, human - pulver og solvens til injektions- /infusionsvæske, opløsning - 500 ie

Berinert 1500 Pulver und Lösungsmittel zur Herstellung einer Injektionslösung. Tyskland - tysk - myHealthbox

berinert 1500 pulver und lösungsmittel zur herstellung einer injektionslösung.

csl behring gmbh - c1-esterase-inhibitor vom menschen - pulver und lösungsmittel zur herstellung einer injektions- oder infusionslösung zur intravenösen anwendung - 1500 ie - c1-inhibitor, aus plasma gewonnen - hereditäres angioödem typ i und ii (hae) therapie und vor einem eingriff durchgeführte prophylaxe des akuten schubes

HAEGARDA 2000 IU Israel - engelsk - Ministry of Health

haegarda 2000 iu

csl behring ltd., israel - c - 1 esterase inhibitor human - powder and solvent for solution for injection - c - 1 esterase inhibitor human 2000 iu/vial - c1- inhibitor,plasma derived - prevention of recurrent hereditary angioedema (hae) attacks in adolescent and adult patients with c1-esterase inhibitor deficiency.

HAEGARDA 3000 IU Israel - engelsk - Ministry of Health

haegarda 3000 iu

csl behring ltd., israel - c - 1 esterase inhibitor human - powder and solvent for solution for injection - c - 1 esterase inhibitor human 3000 iu/vial - c1- inhibitor,plasma derived - prevention of recurrent hereditary angioedema (hae) attacks in adolescent and adult patients with c1-esterase inhibitor deficiency.